The article explains how our fear of cancer is shaped by various factors, and that the fear itself can be harmful.
Somatic Illnesses and Anxiety
Fear of cancer recurrence is fear or worry about cancer recurrence or progress. Fear of recurrence can impact patients’ quality of life and wellbeing. Cancer survivors’ families support them practically and emotionally, making them a vital supplement for official healthcare. Given the well-established important role of the family in dealing with cancer, we compiled the studies that examined the relationship between family-related factors and fear of cancer recurrence (FCR) among cancer survivors (CSs). One of the foremost studies in this field is the FCR model presented by Mellon and colleagues, which included concurrent family stressors and family-caregiver FCR as factors linked to survivor FCR. Our goal was to prepare the ground for a family-based model of FCR that is more comprehensive than the one proposed by Mellon et al. sixteen years ago. The studies included those with samples of adult cancer survivors from different regions of the world. Most of the studies we reviewed are cross-sectional studies. We categorized family-related factors associated with survivor FCR into partner-related factors, including subgroups of disclosure to partner, cognitions of partner, and partner’s sources of support; parenthood-related factors, including having children and parenting stress; family-related factors, including living situation, family history of cancer, family’s perception of the illness, and family characteristics; and social interactions including social support, disclosure, social constraints, and attitudes of others. This review sheds light on how significant others of cancer survivors can affect and be affected by cancer-related concerns of survivors and emphasizes the necessity of further investigation of family-related factors associated with FCR.
Our fear of cancer is in some ways outdated, excessive, and harmful—a phobia. Understanding the history and psychology of that fear, and recognizing its harms, can help.
Case report: Anxiety and depression as initial symptoms in a patient with acute hypoxia and patent foramen ovale
The prevalence of patent foramen ovale (PFO) is 15–35% among adults. The role of right-to-left shunting through the PFO, anxiety, depression, and hypoxemia in the systemic circulation remains poorly understood. Herein, we present the case of a 52-year-old woman with no heart or lung disease, who was admitted due to anxiety for 5 months and had
Source: United Press International – Health NewsA large new study challenges the long-held idea that depression makes people more vulnerable to cancer, finding no association between the mental health condition and most types of cancer. The study, of more than 300,000 adults, found that neither depression nor chronic anxiety were linked to increased odds of developing cancer in the coming years. And when researchers looked at specific types of cancer, the findings were largely the same.
Condition: Cancer PatientsIntervention: Device: Virtual GlassesSponsor: Bahar İNKAYACompleted
Volume 104, Issue 2, April 2023, Page 244-262.
The effect of anxiety and depression on the health-related quality of life of severe acute pancreatitis survivors: structural equation modeling approach
Background Understanding the relationship between anxiety, depression and health-related quality of life (HRQOL) provides important clues to alleviate anxiety, depression and improve HRQOL in patients after severe acute pancreatitis (SAP). The aim of this study was to examine the effects of anxiety and depression on HRQOL in post-SAP patients using structural equation modeling. Methods A
Dealing with secondary psychiatric symptoms while treating patients in clinical settings can be quite challenging. However, in this case study, the authors discuss a female patient with Cushing’s disease, who was initially misdiagnosed with anxiety disorder. Despite multiple attempts with psychiatric intervention, her condition persisted, accompanied by unexplained hypokalemia and hypothyroidism. Thankfully, a visit to
Brief self-affirmation intervention for adults with psoriasis for reducing anxiety and depression and boosting well-being: Evidence from a randomized controlled trial
There are relatively few studies to address mental health implications of self-affirming, especially across groups experiencing a chronic health condition. In this study, short- and longer-term effects of a brief self-affirmation intervention framed in terms of implementation intentions (if-then plans with self-affirming cognitions; S-AII) were evaluated against an active control group (non-affirming implementation intentions; N-AII), matched to the target condition, and mere goal intention condition (a non-active control) in adults with psoriasis. The three pre-registered primary outcomes captured depression, anxiety, and well-being.
Adults with psoriasis (N = 175; Mage = 36.53, s.d. = 11.52) were randomized into S-AII, N-AII, or control. Participants’ mental health outcomes were assessed prior to randomization (at baseline), at week 2 (post-intervention), and at a 1-month follow-up.
Linear mixed models were used and results were reported on the intention-to-treat principle. Analyses revealed that S-AII exerted significantly more improvement in the course of well-being (ds > 0.25), depressive symptoms (ds > −0.40), and anxiety (ds > −0.45) than the N-AII and control group at 2-week post-intervention. Though the differences between groups faded at 1-month follow-up, the within-group changes over time for S-AII in all mental health outcomes remained significant.
Brief and low-intensity S-AII intervention exerted in the short-term a considerable impact on mental health outcomes. The S-AII shows promising results as a relevant public mental health strategy for enhancing well-being and reducing psychological distress. Future studies could consider whether these effects can be further enhanced with booster interventions.